Medical Pharmacology Chapter 33-34:  Anticancer Drugs

Previous Page Next Page

Section Table of Contents

Site Table of Contents

Previous Page Next Page

Section Table of Contents

Site Table of Contents

References

  1. Chabner BA General Principles of Cancer Chemotherapy Chapter 60 in Goodman & Gilman's The Pharmacological Basis of Therapeutics, 12th edition (Brunton LL Chabner BA Knollmann BC, eds; Brunton LL, ed; Blumenthal DK  Murri N Hilal-Dandan R, assoc eds, Knollmann BC, consulting ed, on-line edition) The McGraw-Hill Companies, 2011.

  2. Sausville EA Longo DL Chapter 103e Principles of Cancer Treatment, in Harrison's Online   (Dennis L. Kasper, Anthony S. Fauci, Stephen L. Hauser, Dan L. Longo,  J. Larry Jameson, Joseph Loscalzo, Eds.),  Harrison's Principles of Internal Medicine, 19th edition, The McGraw-Hill Companies, Inc. 2015.

  3. Chu E Sartorelli AC Cancer Chemotherapy Chapter 54 in Basic & Clinical Pharmacology, 13 e (Katzung BG  and Trevor AJ) The McGraw-Hill Companies, 2015 (on-line edition)

  4. Chabner BA Bertino J Cleary J Ortiz T Lane A Supko JG Ryan Chapter 61:  Cytotoxic Agents in Goodman & Gilman's The Pharmacological Basis of Therapeutics, 12th edition (Brunton LL Chabner BA Knollmann BC, eds; Brunton LL, ed; Blumenthal DK  Murri N Hilal-Dandan R, assoc eds, Knollmann BC, consulting ed, on-line edition) The McGraw-Hill Companies, 2011.

  5. Chabner BA Barnes J Neal J Olson E Mujagic H Sequist L Wyham Wilson Longo DL Mitsiades C Richardson P  Chapter 62:  Targeted Therapies:  Tyrosine Kinase Inhibitors, Monoclonal Antibodies and Cytokines  in Goodman & Gilman's The Pharmacological Basis of Therapeutics, 12th edition (Brunton LL Chabner BA Knollmann BC, eds; Brunton LL, ed; Blumenthal DK  Murri N Hilal-Dandan R, assoc eds, Knollmann BC, consulting ed, on-line edition) The McGraw-Hill Companies, 2011.

  6. Moy B Goss P Lee RJ Smith M  Chapter 63:  Natural Products in Cancer Chemotherapy:  Hormones and Related Agents. in Goodman & Gilman's The Pharmacological Basis of Therapeutics, 12th edition (Brunton LL Chabner BA Knollmann BC, eds; Brunton LL, ed; Blumenthal DK  Murri N Hilal-Dandan R, assoc eds, Knollmann BC, consulting ed, on-line edition) The McGraw-Hill Companies, 2011.

  7. Rosenberg SA Robbins PF Phan G Feldman SA Kochenderfer JN  Chapter 14:  Cancer Immunotherapy  in Principles & Practice of Oncology (DeVita, JR VT Lawrence TS Rosenberg SA, eds) 10e Wolters Kluwer Health 2015.

  8. Tew KD Chapter 17:  Alkylating Agents  in Principles & Practice of Oncology (DeVita, JR VT Lawrence TS Rosenberg SA, eds) 10e Wolters Kluwer Health 2015.

  9. Collins JM Cancer Pharmacology Chapter 29 in Abeloff's Clinical Oncology (Niederhuber JE Armitage JO Doroshow JH Kastan MB Tepper JE, eds)  5e Elsevier Churchill Livingstone, Philadelphia, PA 2014.

  10. SEER Training Modules, National Cancer Institute, Types of Chemotherapy Drugs:  Alkylating agents http://training.seer.cancer.gov/treatment/chemotherapy/types.html accessed April 10, 2016.

  11. Noll DM Mason TM Miller PS Formation and Repair of Interstrand Cross-Links in DNA Chem Rev.  106(2):  277-302 February 2006. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2505341/

  12. Roche VF Chapter 42 Cancer and Chemotherapy (in Foye's Principles of Medicinal Chemistry 7e Lemke TL Williams DA Roche VF Zito SW, eds) Wolters Kluwer | Lippincott Williams & Wilkins, 2013.

  13. Kantarjian H Cortes J Chapter 101 Chronic Myeloid Leukemia in Abeloff's Clinical Oncology (Niederhuber JE Armitage JO Doroshow JH Kastan MB Tepper JE, eds)  p. 1944 5e Elsevier Churchill Livingstone, Philadelphia, PA 2014.

  14. Keldsen N Havsteen H Vergote I Bertelsen K Jokobsen A Altretamine (hexamethylmelamine) in the treatment of platinum-resistant ovarian cancer:  a phase II Study  Gynecologic Oncology 88(2): 118-122 2003. https://www.ncbi.nlm.nih.gov/pubmed/12586589

  15. Chan JK Loizzi V Manetta A Berman ML Case Report:  Oral altretamine used as salvage therapy in recurrent ovarian cancer  Gynecologic Oncology 92(1):  368-371, 2004. https://www.ncbi.nlm.nih.gov/pubmed/14751188

  16. Bevers TB Brown PH Colbert Maresso K Hawk ET Cancer prevention, screening and early detection:  Ovarian Cancer Chapter 23  in Abeloff's Clinical Oncology (Niederhuber JE Armitage JO Doroshow JH Kastan MB Tepper JE, eds)  p. 354 5e Elsevier Churchill Livingstone, Philadelphia, PA 2014.

  17. Morgan M Boyd J Drapkin R Seiden MV Cancers arising in the ovary  Chapter 89  in Abeloff's Clinical Oncology (Niederhuber JE Armitage JO Doroshow JH Kastan MB Tepper JE, eds)  p. 1592 5e Elsevier Churchill Livingstone, Philadelphia, PA 2014.

  18. Cannistra SA Gershenson DM Recht A Ovarian cancer, fallopian tube carcinoma, and peritoneal carcinoma. Chapter 76 in Principles & Practice of Oncology (DeVita, JR VT Lawrence TS Rosenberg SA, eds) 10e Wolters Kluwer Health 2015.

  19. Hennessy BT Suh GK Markman M Ovarian cancer. Chapter 28 in The MD Anderson Manual of Medical Oncology 2e (Kantarjian HM Wolff RA Koller CA, eds) The McGraw-Hill Companies, Inc, 2011.

  20. Dorigo O Ovarian Cancer:  Current and Novel Treatment Strategies Stanford University https://www.youtube.com/watch?v=tnMXOuVxsRo

  21. Heilman J An ovarian cancer as seen on CT (2011) https://commons.wikimedia.org/wiki/File:POvarianCA.png

  22. Westin JR Konoplev SN Fayad LE Mederios lJ  Chapter 8:  Aggressive B-cell Lymphoma in The MD Anderson Manual of Medical Oncology (Kantarijian HM and Wolff RA, eds) 3e McGraw-Hill Education 2016.

  23. Roche VF Cancer and Chemotherapy Chapter 3:: Therapeutic Classes of Anticancer Drugs-Nitrogen Mustards and Aziridine-Mediated Alkylators. in Foye's Priniciples of Medicinal Chemistry (Lemke TL Williams DA, eds; associate eds, Roche VF Zito SW) 7e Lippinoctt, Williams & Wilkins, a Wolters Kluwer business, 2003.

  24. Konety BR Carroll PR Chapter 21.  Urothelial Carcinoma:  Cancers of the Bladder, Ureter, & Renal Pelvis in Smith & Tanagho's General Urology 18e (McAninch JW Lue TF, eds) The McGraw-Hill Companies, 2013.

  25. Rosenstock AS Hortobagi GN Chapter 27:  Early-Stage and Locally Advanced Breast Cancer in The MD Anderson Manual of Medical Oncology (Kantarijian HM and Wolff RA, eds) 3e McGraw-Hill Eduation 2016.

  26. Brufsky AM Hurvitz S O'Shaughnessy J Perez EA Rugo HS Seidman AD Case Study:  Metastatic Triple-Negative Breast Cancer https://www.youtube.com/watch?v=a9ZoFmjJjB4 ; Case Study Discussion:  http://www.onclive.com/peer-exchange-archive/mbc-challenges (Episode 16).

  27. Gerson SL Bulgar AD Weeks LD Chabner BA  Chapter 14:  Part A:  Alkylating Agents:  Classical Alkylating Agents in Cancer Chemotherapy and Biotherapy:  Principles and Practice, 5e (Chabner BA & Longo DL, eds) 2011.

  28. Wright LG Maculopapular Skin Rashes Associated with High-Dose Chemotherapy:  Prevalence and Risk Factors.  Oncology Nursing Forum 33(6):  1095-1103.

 

Disclaimer

This Web-based pharmacology and disease-based integrated teaching site is based on reference materials, that are believed reliable and consistent with standards accepted at the time of development. Possibility of human error and on-going research and development in medical sciences do not allow assurance that the information contained herein is in every respect accurate or complete. Users should confirm the information contained herein with other sources. This site should only be considered as a teaching aid for undergraduate and graduate biomedical education and is intended only as a teaching site. Information contained here should not be used for patient management and should not be used as a substitute for consultation with practicing medical professionals. Users of this website should check the product information sheet included in the package of any drug they plan to administer to be certain that the information contained in this site is accurate and that changes have not been made in the recommended dose or in the contraindications for administration.  Advertisements that appear on this site are not reviewed for content accuracy and it is the responsibility of users of this website to make individual assessments concerning this information.  Medical or other information  thus obtained should not be used as a substitute for consultation with practicing medical or scientific or other professionals.